Cardiol Therapeutics（CRDL.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他66.86%
对冲基金18.24%
机构投资者11.97%
个人与内部人士2.92%

主要股东

主要股东最新
股东
MM Asset Management Inc	18.24%	2,131.01 万	4.52%	+595.78 万	2026/06/30
MM Asset Management Inc	13.32%	1,535.23 万	13.11%	+1,514.34 万	2026/03/31
Tejara Capital Limited	4.44%	511.38 万	0.15%	-1.63 万	2026/06/30
Tejara Capital Limited	4.38%	511.38 万	0.21%	-1.63 万	2026/06/30
Ikarian Capital, LLC	2.85%	332.50 万	0.41%	+60.00 万	2026/06/30
Ikarian Capital, LLC	2.36%	272.50 万	--	+272.50 万	2026/03/31
David ElsleyPresident, CEO & Director	1.17%	134.45 万	0.04%	+0	2026/05/07
David ElsleyPresident, CEO & Director	1.15%	134.45 万	0.05%	+0	2026/05/07
Boothbay Fund Management, LLC	0.84%	97.57 万	0.12%	+18.08 万	2026/06/30
Citadel Advisors LLC	0.71%	81.99 万	0.71%	+81.99 万	2026/03/31
Boothbay Fund Management, LLC	0.69%	79.49 万	--	+79.49 万	2026/03/31
Citadel Advisors LLC	0.68%	79.65 万	0.05%	-2.34 万	2026/06/30
Renaissance Technologies LLC	0.67%	77.28 万	0.47%	+54.30 万	2026/06/30
Renaissance Technologies LLC	0.66%	77.28 万	0.46%	+54.30 万	2026/06/30
Two Sigma Investments, LP	0.64%	74.69 万	0.16%	+21.27 万	2026/06/30
Andrew HamerChief Medical Officer and Head of Research & Development	0.58%	66.99 万	0.09%	+0	2025/12/03
Andrew HamerChief Medical Officer and Head of Research & Development	0.57%	66.99 万	0.03%	+0	2025/12/03
Two Sigma Investments, LP	0.46%	53.42 万	0.06%	+12.73 万	2026/03/31
Peter PekosIndependent Director	0.44%	50.60 万	0.01%	+0	2026/06/30
Peter PekosIndependent Director	0.43%	50.60 万	0.02%	+0	2026/06/30